Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
TU-100 is a gastrointestinal drug produced from the three botanical raw materials, Asian
ginseng, Zanthoxylum fruit (Japanese pepper), and ginger, based on proprietary aqueous
decoction and granulation technology. The aim of this study is to assess the effect of TU-100
on post-operative quality of life during the 4 week postoperative period after straight,
hand-assisted, or robot-assisted laparoscopic colectomy. Optimal efficacy parameters for
subsequent outcome studies also will be explored.